Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.
Occludin is a key component of tight junctions. Reduced occludin expression has been linked to cancer progression in individual tumor types, but a comprehensive and standardized analysis across human tumor types is lacking. To study the prevalence and clinical relevance of occludin expression in can...
Saved in:
| Main Authors: | Seyma Büyücek, Florian Viehweger, Viktor Reiswich, Natalia Gorbokon, Viktoria Chirico, Christian Bernreuther, Florian Lutz, Simon Kind, Ria Schlichter, Sören Weidemann, Till S Clauditz, Andrea Hinsch, Ahmed Abdulwahab Bawahab, Frank Jacobsen, Andreas M Luebke, David Dum, Claudia Hube-Magg, Martina Kluth, Katharina Möller, Anne Menz, Andreas H Marx, Till Krech, Patrick Lebok, Christoph Fraune, Guido Sauter, Ronald Simon, Eike Burandt, Sarah Minner, Stefan Steurer, Maximilian Lennartz, Morton Freytag |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0321105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors
by: Maria Christina Tsourlakis, et al.
Published: (2025-07-01) -
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
by: Seyma Büyücek, et al.
Published: (2024-12-01) -
High prevalence of p16 staining in malignant tumors.
by: Noémi De Wispelaere, et al.
Published: (2022-01-01) -
Correction: High prevalence of p16 staining in malignant tumors.
by: Noémi De Wispelaere, et al.
Published: (2025-01-01) -
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
by: Viktoria Chirico, et al.
Published: (2025-08-01)